NEW YORK (GenomeWeb News) - The National Institutes of Health extended the submission date for its Commercialization Assistance Program to Aug. 7.
 
The NIH SBIR CAP connects SBIR Phase II awardees with partners and investors to help move the products into the marketplace. The program is appropriate for researchers with clinical products looking for investments or alliances.
 
STTR awardees are not eligible to participate at this time.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.